Reducing the learning curve for the treatment of morphoeic (sclerosing) basal cell carcinoma of the face

Scandinavian Journal of Plastic and Reconstructive Surgery and Hand Surgery

Volumn 42, Issue 3, 2008, Pages 122-126

  Erba, Paolo ^a   Wettstein, Reto ^a   Rieger, Ulrich M ^a   Beltraminelli, Helmut ^a   Pierer, Gerhard ^a   Kalbermatten, Daniel F ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Frozen section analysis; Loupe magnification; Morphoeic basal cell carcinoma; Preoperative planning; Safety margin; Skin tumour; Varioscope

Indexed keywords

AGED; ARTICLE; BASAL CELL CARCINOMA; CLINICAL COMPETENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; FACE TUMOR; FEMALE; HUMAN; MALE; MEDICAL EDUCATION; METHODOLOGY; MICROSURGERY; MINIMAL RESIDUAL DISEASE; PLASTIC SURGERY; PREOPERATIVE CARE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SKIN TUMOR;

AGED; AGED, 80 AND OVER; CARCINOMA, BASAL CELL; CLINICAL COMPETENCE; FACIAL NEOPLASMS; FEMALE; HUMANS; INTERNSHIP AND RESIDENCY; MALE; MICROSURGERY; NEOPLASM, RESIDUAL; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; SKIN NEOPLASMS;

EID: 45749112653     PISSN: 02844311     EISSN: 16512073     Source Type: Journal    
DOI: 10.1080/02844310801924373     Document Type: Article

References (18)

1. Salasche SJ, Amonette RA. Morpheaform basal-cell epitheliomas. A study of subclinical extensions in a series of 51 cases. J Dermatol Surg Oncol 1981;7:387-94.
2. Thomas DJ, King AR, Peat BG. Excision margins for nonmelanotic skin cancer. Plast Reconstr Surg 2003;112:57-63.
3. Dixon AY, Lee SH, McGregor DH. Factors predictive of recurrence of basal cell carcinoma. Am J Dermatopathol 1989;11:222-32.
4. Rippey JJ. Why classify basal cell carcinomas? Histopathology 1998;32:393-8.
5. Robinson JK, Fisher SG. Recurrent basal cell carcinoma after incomplete resection. Arch Dermatol 2000;136:1318-24.
6. Lang PG Jr, Maize JC. Histologic evolution of recurrent basal cell carcinoma and treatment implications. J Am Acad Dermatol 1986;14:186-96.
7. Nagore E, Grau C, Molinero J, Fortea JM. Positive margins in basal cell carcinoma: relationship to clinical features and recurrence risk. A retrospective study of 248 patients. J Eur Acad Dermatol Venereol 2003;17:167-70.
8. Erba P, Farhadi J, Wettstein R, Arnold A, Harr T, Pierer G. Morphoeic basal cell carcinoma of the face. Scand J Plast Reconstr Surg Hand Surg 2007;41:184-8.
9. Kumar P, Orton CI, McWilliam LJ, Watson S. Incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit. Br J Plast Surg 2000;53:563-6.
10. Wettstein R, Kalbermatten DF, Rieger U, Farhadi J, Harr T, Pierer G. High magnification assessment improves complete resection of facial tumors. Ann Plast Surg 2006;57:517-20.
11. Rippey JJ, Rippey E. Characteristics of incompletely excised basal cell carcinomas of the skin. Med J Aust 1997;166:581-3.
12. Netscher DT, Spira M. Basal cell carcinoma: an overview of tumor biology and treatment. Plast Reconstr Surg 2004;113:74E-94E.
13. Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002;138:1043-51.
14. Takenouchi T, Nomoto S, Ito M. Factors influencing the linear depth of invasion of primary basal cell carcinoma. Dermatol Surg 2001;27:393-6.
15. Orengo IF, Salasche SJ, Fewkes J, Khan J, Thornby J, Rubin F. Correlation of histologic subtypes of primary basal cell carcinoma and number of Mohs stages required to achieve a tumor-free plane. J Am Acad Dermatol 1997;37:395-7.
16. Hendrix JD Jr, Parlette HL. Duplicitous growth of infiltrative basal cell carcinoma: analysis of clinically undetected tumor extent in a paired case-control study. Dermatol Surg 1996;22:535-9.
17. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990;23:1118-26.
18. Marks R. An overview of skin cancers. Incidence and causation. Cancer 1995;75:607-12.